All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Current approaches to enhancing oxime reactivator delivery into the brain

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F60162694%3AG44__%2F19%3A00536978" target="_blank" >RIV/60162694:G44__/19:00536978 - isvavai.cz</a>

  • Alternative codes found

    RIV/00179906:_____/19:10400302

  • Result on the web

    <a href="https://www.sciencedirect.com/science/article/pii/S0300483X19301581" target="_blank" >https://www.sciencedirect.com/science/article/pii/S0300483X19301581</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1016/j.tox.2019.05.006" target="_blank" >10.1016/j.tox.2019.05.006</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Current approaches to enhancing oxime reactivator delivery into the brain

  • Original language description

    The misuse of organophosphate compounds still represents a current threat worldwide. Treatment of poisoning with organophosphates (OPs) remains unsatisfactorily resolved despite the extensive investment in research in academia. There are no universal, effective and centrally-active acetylcholinesterase (AChE) reactivators to countermeasure OP intoxication. One major obstacle is to overcome the blood-brain barrier (BBB). The central compartment is readily accessible by the OPs which are lipophilic bullets that can easily cross the BBB, whereas first-line therapeutics, namely oxime-based AChE reactivators and atropine, do not cross or do so rather slowly. The limitation of oxime-based AChE reactivators can be ascribed to their chemical nature, bearing a positive charge which is essential either for their AChE affinity or their reactivating potency. The aim of this article is to review the methods for targeting the brain by oxime reactivators that have been developed so far. Approaches using prodrugs, lipophilicity enhancement, or sugar-based oximes have been rather unsuccessful. However, other strategies have been more promising, such as the use of nanoparticles or co-administration of the reactivator with efflux transporter inhibitors. Encouraging results have also been associated with intranasal delivery, but research in this field is still at the beginning. Further research of auspicious approaches is inevitable

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database

  • CEP classification

  • OECD FORD branch

    30104 - Pharmacology and pharmacy

Result continuities

  • Project

    <a href="/en/project/NV17-32801A" target="_blank" >NV17-32801A: Centrally acting antidotes for the treatment of organophosphorus poisoning</a><br>

  • Continuities

    S - Specificky vyzkum na vysokych skolach<br>I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2019

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Toxicology

  • ISSN

    0300-483X

  • e-ISSN

    0300-483X

  • Volume of the periodical

    423

  • Issue of the periodical within the volume

    1

  • Country of publishing house

    IE - IRELAND

  • Number of pages

    9

  • Pages from-to

    75-83

  • UT code for WoS article

    000483417200006

  • EID of the result in the Scopus database

    2-s2.0-85066068619